WO2004005458A3 - Functional sites - Google Patents

Functional sites Download PDF

Info

Publication number
WO2004005458A3
WO2004005458A3 PCT/IB2003/004491 IB0304491W WO2004005458A3 WO 2004005458 A3 WO2004005458 A3 WO 2004005458A3 IB 0304491 W IB0304491 W IB 0304491W WO 2004005458 A3 WO2004005458 A3 WO 2004005458A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
disease
functional sites
computer
useful
Prior art date
Application number
PCT/IB2003/004491
Other languages
French (fr)
Other versions
WO2004005458A2 (en
Inventor
John A Stamatoyannopoulos
Michael Mcarthur
Peter J Sabo
Original Assignee
Regulome Corp
John A Stamatoyannopoulos
Michael Mcarthur
Peter J Sabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regulome Corp, John A Stamatoyannopoulos, Michael Mcarthur, Peter J Sabo filed Critical Regulome Corp
Priority to AU2003276494A priority Critical patent/AU2003276494A1/en
Publication of WO2004005458A2 publication Critical patent/WO2004005458A2/en
Publication of WO2004005458A3 publication Critical patent/WO2004005458A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Functional site sequences, their genomic positions, and methods of their use are described. The sequences are individually useful for their abilities to regulate gene expression. Sets and arrays of sequences are particularly useful for the identification of cells and tissues, the detection and diagnosis of disease, and the discovery of medicinal agents, and gene regulatory mechanisms, including those associated with disease. The sequences and their locations also are highly valuable when used by computer programs for comparing known genetic sequences by a large variety of computer manipulations.
PCT/IB2003/004491 2002-06-13 2003-06-13 Functional sites WO2004005458A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003276494A AU2003276494A1 (en) 2002-06-13 2003-06-13 Functional sites

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38791002P 2002-06-13 2002-06-13
US38788702P 2002-06-13 2002-06-13
US60/387,910 2002-06-13
US60/387,887 2002-06-13

Publications (2)

Publication Number Publication Date
WO2004005458A2 WO2004005458A2 (en) 2004-01-15
WO2004005458A3 true WO2004005458A3 (en) 2007-12-21

Family

ID=29739965

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2003/018714 WO2003106635A2 (en) 2002-06-13 2003-06-13 Functional sites
PCT/IB2003/004491 WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2003/018714 WO2003106635A2 (en) 2002-06-13 2003-06-13 Functional sites

Country Status (2)

Country Link
AU (2) AU2003276494A1 (en)
WO (2) WO2003106635A2 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121311A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in livestock
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US20040019915A1 (en) 2002-04-01 2004-01-29 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
JP2006516193A (en) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド Rapid identification of pathogens in humans and animals
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
CA2567839C (en) 2004-05-24 2011-06-28 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
CA2593086A1 (en) * 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
EP1869180B1 (en) 2005-03-03 2013-02-20 Ibis Biosciences, Inc. Compositions for use in identification of polyoma viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8026084B2 (en) 2005-07-21 2011-09-27 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
EP2006382B1 (en) * 2006-04-11 2016-08-03 Eisai R&D Management Co., Ltd. Dopamine-producing neuron progenitor cell marker 187a5
WO2008143627A2 (en) 2006-09-14 2008-11-27 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (en) 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Methods for rapid foresnsic dna analysis
WO2008113773A2 (en) * 2007-03-16 2008-09-25 Biorigen S.R.L. Gene expression regulation technology and noncoding rnas for diagnosis and therapy
US7695916B2 (en) * 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
CN102264916B (en) * 2008-07-25 2014-08-20 英福康姆株式会社 Novel oncogene nrf2
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2352743A4 (en) * 2008-11-04 2012-04-25 Idera Pharmaceuticals Inc Modulation of toll-like receptor 5 expression by antisense oligonucleotides
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc Ionization probe assemblies
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011047307A1 (en) 2009-10-15 2011-04-21 Ibis Biosciences, Inc. Multiple displacement amplification
TW202344270A (en) 2010-09-29 2023-11-16 美商艾澤西公司 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
JP6090937B2 (en) 2011-07-27 2017-03-08 国立大学法人京都大学 Novel dopaminergic neural progenitor cell marker
WO2015024017A2 (en) * 2013-08-16 2015-02-19 President And Fellows Of Harvard College Rna polymerase, methods of purification and methods of use
CA2960209C (en) 2014-09-04 2023-08-29 Memorial Sloan-Kettering Cancer Center Globin gene therapy for treating hemoglobinopathies
US10450572B2 (en) * 2016-08-12 2019-10-22 Regents Of The University Of Minnesota Androgen receptor variant inhibitors and methods of using
CN114864002B (en) * 2022-04-28 2023-03-10 广西科学院 Transcription factor binding site recognition method based on deep learning

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029086A2 (en) * 2000-10-02 2002-04-11 Bayer Corporation Nucleic acid sequences differentially expressed in cancer tissue

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029086A2 (en) * 2000-10-02 2002-04-11 Bayer Corporation Nucleic acid sequences differentially expressed in cancer tissue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PHILIPP ET AL.: "Molecular analysis of regulation of gene expression of the human erythroid anion exchanger (AE) 1", FEBS LETTERS, vol. 438, 1998, pages 315 - 320 *

Also Published As

Publication number Publication date
AU2003245488A1 (en) 2003-12-31
WO2004005458A2 (en) 2004-01-15
WO2003106635A9 (en) 2010-01-21
AU2003276494A1 (en) 2004-01-23
AU2003276494A8 (en) 2004-01-23
AU2003245488A8 (en) 2010-02-11
WO2003106635A2 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
WO2004005458A3 (en) Functional sites
WO2006028867A3 (en) Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
WO2008016356A3 (en) Genemap of the human genes associated with psoriasis
WO2006138696A3 (en) Genemap of the human genes associated with longevity
WO2006048291A3 (en) Transcriptome microarray technology and methods of using the same
WO2007016668A3 (en) Methods and compositions for disease prognosis based on nucleic acid methylation
WO2007025085A8 (en) Genemap of the human genes associated with crohn's disease
WO2001089584A3 (en) Contrast agents
WO2008112177A8 (en) Genemap of the human genes associated with schizophrenia
WO2000050639A3 (en) Gene sequence variations with utility in determining the treatment of disease
WO2006002378A3 (en) Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
WO2008118258A3 (en) Genemap of the human genes associated with adhd
WO2004082617A3 (en) Biological markers for diagnosing rheumatoid arthritis
WO2008083331A3 (en) Diagnostic and therapeutic target for autoimmune diseases and uses thereof
WO2008067195A3 (en) Genemap of the human genes associated with crohn's disease
WO2007143752A3 (en) Targets in breast cancer for prognosis or therapy
WO2008085601A3 (en) Genemap of the human genes associated with asthma disease
WO2009064973A3 (en) Diagnostic kits and methods for scd or sca therapy selection
WO2002064766A3 (en) Bax-responsive genes for drug target identification in yeast and fungi
WO2005119640A3 (en) Interfering stem-loop sequences and method for identifying
AU2002303437A1 (en) Isolation of neural stem cells using gangliosides and other surface markers
WO2005085473A3 (en) Polymorphisms in the epidermal growth factor receptor gene promoter
WO2000070340A3 (en) Materials and methods relating to disease diagnosis
NO20020470D0 (en) Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
WO2007124820A3 (en) Method for in vitro monitoring of postoperative changes following liver transplantation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP